Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Syngene International Ltd. ( (IN:SYNGENE) ) just unveiled an update.
Syngene International has amended its policy on determining the materiality of events and information under SEBI Listing Regulations, reflecting a planned change in key managerial personnel responsible for stock exchange disclosures. The move is intended to ensure clarity and continuity in how the company evaluates and communicates price-sensitive information to the market.
The board has approved that Managing Director and CEO Peter Bains will step down at the close of business on June 30, 2026, with Siddharth Mittal taking over as Managing Director and CEO from July 1, 2026. From that date, Mittal will be among the designated executives, alongside CFO Deepak Jain and Company Secretary and Compliance Officer Chethan Yogesh, authorized to determine material events and make regulatory disclosures, signaling a planned leadership transition without changes to the broader disclosure framework.
More about Syngene International Ltd.
Syngene International Ltd. is an India-based contract research and manufacturing organization operating in the lifesciences sector. The company provides research, development and manufacturing services to global pharmaceutical, biotechnology and other industries from its facilities in Bengaluru, with a focus on supporting drug discovery and development.
Average Trading Volume: 162,441
Technical Sentiment Signal: Sell
Current Market Cap: 176.4B INR
Learn more about SYNGENE stock on TipRanks’ Stock Analysis page.